STRIDES PHARMA SCI LTD (STAR)

NSE: ₹1,027.20
BSE: ₹1,027.35
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Intimation of Schedule of Analyst/ Institutional Investors Meet

2026-06-08 20:15:52
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 – Reminder To Shareholders Regarding Unclaimed Dividends And Transfer To IEPF

Reminder to Shareholders regarding Unclaimed Dividends and Transfer to IEPF

2026-06-01 21:45:19
Intimation Of Effective Date For The Scheme Of Demerger Involving Arco Lab Private Limited (“Arco Lab”) And Pivot Path Private Limited (“Pivot Path”)

Intimation of Effective Date for Scheme of Demerger involving Arco Lab Private Limited ("Arco Lab") and ("Pivot Path Private Limited").

2026-06-01 17:34:03
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Schedule of Analyst/ Institutional Investor's Meeting - as enclosed.

2026-05-28 20:11:00
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Schedule of Analyst/ Institutional Investor's Meet - as enclosed.

2026-05-28 20:07:32
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Schedule of Analyst/ Institutional Investor's meet - as enclosed

2026-05-28 20:05:01

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 929.99 999.43 1,037.67 1,084.04 1,087.51 1,201.11 1,153.67 1,190.39 1,119.74 1,220.83 1,194.65 1,323.47
YOY Revenue Growth % -1.07% 11.41% 19.98% 9.9% 16.94% 20.18% 11.18% 9.81% 2.96% 1.64% 3.55% 11.18%
Other Income 8.65 35.85 8.75 -13.55 12.72 28.41 5.62 11.98 8.58 27.14 106.86 8.13
Total Income 938.64 1,035.28 1,046.42 1,070.49 1,100.22 1,229.52 1,159.28 1,202.37 1,128.32 1,247.97 1,301.51 1,331.60
Total Expenses + 899.41 984.99 974.37 984.22 999.51 1,097.98 1,043.96 1,071.71 998.01 1,085.03 1,052.70 1,178.59
Cost of Materials Consumed 269.85 342.30 375.13 353.84 364.21 448.85 476.58 269.73 260.58 429.76 459.71 408.88
Employee Benefit Expense 167.53 199.93 184.49 199.17 212.17 219.41 215.64 222.86 225.52 226.78 229.54 247.11
Other Expenses 210.92 228.28 238.12 238.91 237.91 247.97 247.59 250.69 231.86 247.22 266.22 300.40
Operating Profit 30.58 14.44 63.30 99.82 88.00 103.13 109.71 118.69 121.73 135.80 141.94 144.88
OPM % 3.3% 1.4% 6.1% 9.2% 8.1% 8.6% 9.5% 10% 10.9% 11.1% 11.9% 10.9%
Profit Before Tax + 33.25 -114.64 61.99 78.20 96.98 127.67 112.89 103.25 121.94 154.17 245.51 146.60
Tax Expense 42.61 34.81 7.93 67.76 28.67 34.01 22.85 17.63 16.35 22.64 37.38 17.32
Tax % 128.2% - 12.8% 86.6% 29.6% 26.6% 20.2% 17.1% 13.4% 14.7% 15.2% 11.8%
Profit After Tax -9.36 -149.46 54.06 10.44 68.31 93.66 90.04 85.62 105.59 131.52 208.12 129.28
EPS (Basic) -0.79 -14.54 5.43 1.98 7.64 10.14 9.56 8.92 10.81 13.84 21.93 13.77

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 4,858.68 4,565.34 4,051.12 3,688.39 3,070.25 3,315.87 2,751.97
YOY Revenue Growth % 6.43% 12.69% 9.83% 20.13% -7.41% 20.49% -
Other Income 150.71 58.72 39.70 90.33 131.99 51.43 53.11
Total Income 5,009.40 4,624.06 4,090.83 3,778.72 3,202.24 3,367.30 2,805.08
Total Expenses + 4,314.34 4,203.63 3,842.99 3,762.60 3,500.11 3,037.39 2,133.94
Cost of Materials Consumed 1,558.92 1,475.89 1,341.11 1,441.68 1,090.93 1,390.42 1,020.35
Employee Benefit Expense 928.96 862.76 751.13 732.02 646.91 550.15 442.56
Other Expenses 1,045.70 919.80 916.23 899.30 941.13 798.10 671.03
Operating Profit 544.35 361.70 208.14 -74.21 -429.86 278.48 618.03
OPM % 11.2% 7.9% 5.1% -2% -14% 8.4% 22.5%
Profit Before Exceptional 695.06 420.42 247.84 16.12 -297.88 329.91 239.59
Exceptional Items -26.84 64.66 -189.05 -17.03 -243.83 43.35 -77.68
Profit Before Tax + 668.22 485.08 58.79 -0.92 -541.70 373.26 161.91
Tax Expense 93.70 -3,112.43 153.11 211.41 -67.45 115.53 131.33
Tax % 14% -641.6% 260.4% - - 31% 81.1%
Profit After Tax 574.52 3,597.51 -94.31 -212.33 -474.25 257.73 30.58
EPS (Basic) 60.34 390.54 -7.76 -22.49 -51.28 29.96 4.06

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 3,313.89 2,949.81 2,870.76 3,395.06 3,614.03 4,197.79 0.00
Property, Plant & Equipment 992.43 880.69 878.67 1,324.29 1,457.42 1,271.85 0.00
Capital Work in Progress 161.12 99.65 79.88 48.26 56.23 227.60 0.00
Non-Current Investments 278.88 329.03 7.63 53.04 540.34 598.00 0.00
Goodwill 594.42 546.57 529.41 513.76 485.91 480.54 0.00
Other Intangible Assets 513.50 460.85 445.10 460.37 390.13 398.74 0.00
Current Assets + 3,612.79 3,098.91 2,969.00 3,135.25 3,361.83 2,817.23 0.00
Inventories 1,634.79 1,277.57 1,126.24 1,146.51 1,173.80 1,200.70 0.00
Trade Receivables 1,288.96 1,202.94 1,141.87 1,299.40 1,207.30 1,106.86 0.00
Cash and Cash Equivalents 188.70 112.56 161.02 303.50 170.73 125.83 0.00
Current Investments 0.00 69.50 105.76 50.84 0.00 99.41 0.00
LIABILITIES & EQUITY
Total Equity 3,149.34 2,586.46 2,071.71 2,172.88 2,383.32 2,814.00 0.00
Equity Share Capital 92.17 92.16 91.90 90.30 89.79 89.68 0.00
Other Equity 3,015.39 2,459.67 2,033.66 2,121.96 2,269.44 2,686.98 0.00
Non-Current Liabilities 882.40 870.74 888.79 1,475.34 1,180.87 1,462.67 0.00
Current Liabilities 2,895.49 2,591.52 2,879.26 2,990.20 3,411.68 2,738.35 0.00
Total Liabilities 3,777.90 3,462.26 3,768.05 4,465.54 4,592.55 4,201.02 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 702.52 684.37 701.07 44.41 -257.82 481.44 0.00
Cash from Investing Activities -173.04 -89.69 -150.25 302.47 -118.73 -520.82 0.00
Cash from Financing Activities -453.41 -642.58 -693.32 -213.92 421.32 -15.80 0.00
Net Increase/Decrease in Cash 76.13 -48.43 -142.48 132.77 44.90 -56.40 0.00